Modulation of endothelial cell proliferation by retinoid x receptor agonists

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.385, Iss.2, 1999-12, pp. : 255-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats

By Ogasawara Akemi Murakami Yoshiki Yakushiji Nobumasa Ohsawa Fuminori Kusaba Jun-ichi Aiba Tetsuya Kurosaki Yuji Kakuta Hiroki

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 9, 2011-09 ,pp. : 1060-1067

Informa Healthcare

Access to resources Recommend Favorite

Retinoid X receptor ligands: a patent review (2007 – 2013)

By Yamada Shoya Kakuta Hiroki

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 443-452

Informa Healthcare

Access to resources Recommend Favorite

Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors

Current Drug Metabolism, Vol. 17, Iss. 2, 2016-02 ,pp. : 118-128

Bentham Science Publishers

Access to resources Recommend Favorite

Computer Simulations of the Retinoid X Receptor: Conformational Dynamics and Allosteric Networks

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 6, 2017-01 ,pp. : 731-741

Bentham Science Publishers

Access to resources Recommend Favorite

Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 6, 2017-01 ,pp. : 696-707

Bentham Science Publishers

Access to resources Recommend Favorite